First Clinical Study to Evaluate Safety, Tolerability & PK of DX243 in Healthy Volunteers and Patients With Hearing Loss
Conditions
Age-related Hearing Loss
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Centre hospitalier Universitaire de Liège Sart Tilman, Liège, Liège, Belgium
Contact: Study coordinator (Guillaume Gersdorff, MD) · Guillaume.Gersdorff@chuliege.be · +32 043232323